News

17 November 2021

BAP Pharma awarded EcoVadis Silver Sustainability Rating

BAP Pharma are excited and proud to announce that we have achieved a Silver rating in the recent EcoVadis Sustainability ratings, placing the company within the 90th percentile of all rated companies worldwide.

EcoVadis review more than 75,000 companies based on four main areas:

  • Environment
  • Labour & Human Rights
  • Ethics
  • Sustainable Procurement

 

The achievement of the Silver rating represents an important recognition that underlines BAP Pharma’s commitment to Corporate Social Responsibility. Having achieved a Bronze level in 2020, our silver certification represents a further step in our sustainability path and recognises our efforts to proactively take responsibility for the long-term environmental, economic and ethical aspects of our corporate activities. It also recognises our continuous commitment to operational and environmental excellence.

The Silver Sustainability rating is the result of the work of the BAP Pharma team, which involves representatives of the main company functions, with the aim to integrate sustainability into our business and corporate values.

We are proud to have improved our Sustainability rating from a Bronze to a Silver medal and we will be aiming to achieve the Gold rating in the next evaluation.

 

“We are extremely proud to have obtained a Silver sustainability award from the EcoVadis 2021 ratings, which recognises our ongoing commitment to our Corporate Social Responsibility. I would like to thank all of our amazing staff and their efforts in achieving this great success.”.

Dr. Bashir Pakar, Founder and Managing Director of BAP Pharma.

 

You Might Also Like

BAP US New Headquarters

BAP Pharma first set up our US operations in Landing, New Jersey in 2016 and through our extraordinary continuous success and growth, we have enabled reinvestment into the business and our people, whilst facilitating the purchase and refurbishment of new office and operational premises. BAP US – 50 Randolph Road,

BAP US New Headquarters

Minority Supplier Development UK Report 2021

We are excited and proud to announce that BAP Pharma have ranked 78th in the Minority Supplier Development UK Report 2021 – the first ever list of the country’s top 100 minority businesses. The Minority Supplier Development UK (MSDUK) is the UK’s premier not-for-profit membership organisation, championing diversity and inclusion

Minority Supplier Development UK Report 2021

BAP Pharma Granted Secondary Packaging and Labelling Licence

BAP Pharma are pleased to announce that the Government of Upper Bavaria (Regierung von Oberbayern) have granted a Secondary Packaging and Labelling licence, to our German facility. The new licence will enable BAP Pharma to offer bespoke Clinical Trial Secondary Packaging and Labelling services, to complement our award-winning Comparator Sourcing

BAP Pharma Granted Secondary Packaging and Labelling Licence